These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17200223)

  • 1. BiDil for heart failure in black patients: The U.S. Food and Drug Administration perspective.
    Temple R; Stockbridge NL
    Ann Intern Med; 2007 Jan; 146(1):57-62. PubMed ID: 17200223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BiDil for heart failure in black patients: implications of the U.S. Food and Drug Administration approval.
    Bibbins-Domingo K; Fernandez A
    Ann Intern Med; 2007 Jan; 146(1):52-6. PubMed ID: 17200222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flaws in the U.S. Food and Drug Administration's rationale for supporting the development and approval of BiDil as a treatment for heart failure only in black patients.
    Ellison GT; Kaufman JS; Head RF; Martin PA; Kahn JD
    J Law Med Ethics; 2008; 36(3):449-57. PubMed ID: 18840235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BiDil for heart failure in black patients.
    Kahn JD
    Ann Intern Med; 2007 Aug; 147(3):215; author reply 215-6. PubMed ID: 17679713
    [No Abstract]   [Full Text] [Related]  

  • 5. BiDil for heart failure in black patients.
    Bibbins-Domingo K; Fernandez A
    Ann Intern Med; 2007 Aug; 147(3):214-5; author reply 215-6. PubMed ID: 17679712
    [No Abstract]   [Full Text] [Related]  

  • 6. Misreading race and genomics after BiDil.
    Kahn J
    Nat Genet; 2005 Jul; 37(7):655-6. PubMed ID: 15990879
    [No Abstract]   [Full Text] [Related]  

  • 7. U.S. to review drug intended for one race.
    Saul S
    N Y Times Web; 2005 Jun; ():A1, A15. PubMed ID: 15966118
    [No Abstract]   [Full Text] [Related]  

  • 8. BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.
    Carmody MS; Anderson JR
    Cardiol Rev; 2007; 15(1):46-53. PubMed ID: 17172884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidil: recontextualizing the race debate.
    Séguin B; Hardy B; Singer PA; Daar AS
    Pharmacogenomics J; 2008 Jun; 8(3):169-73. PubMed ID: 18195727
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescribing BiDil: is it black and white?
    Haga SB; Ginsburg GS
    J Am Coll Cardiol; 2006 Jul; 48(1):12-4. PubMed ID: 16814642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The paradox of race in the Bidil debate.
    Crawley L
    J Natl Med Assoc; 2007 Jul; 99(7):821-2. PubMed ID: 17668653
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA approves heart drug for black patients.
    Meadows M
    FDA Consum; 2005; 39(5):8-9. PubMed ID: 16419285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Race-based therapeutics.
    Bloche MG
    N Engl J Med; 2004 Nov; 351(20):2035-7. PubMed ID: 15533852
    [No Abstract]   [Full Text] [Related]  

  • 14. "Ethnic drugs".
    Kahn J
    Hastings Cent Rep; 2005; 35(1):1 p following 48. PubMed ID: 15799501
    [No Abstract]   [Full Text] [Related]  

  • 15. Underuse of hydralazine and isosorbide dinitrate for heart failure in patients of African ancestry: a cross-European survey.
    Brewster LM
    ESC Heart Fail; 2019 Jun; 6(3):487-498. PubMed ID: 30892835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure.
    Ofili E; Anand I; Williams RA; Akinboboye O; Xu L; Puckrein G
    Adv Ther; 2017 Aug; 34(8):1976-1988. PubMed ID: 28707284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race-based medicine and justice as recognition: exploring the phenomenon of BiDil.
    Yu JH; Goering S; Fullerton SM
    Camb Q Healthc Ethics; 2009; 18(1):57-67. PubMed ID: 19091146
    [No Abstract]   [Full Text] [Related]  

  • 18. Isosorbide dinitrate and hydralazine hydrochloride: a review of efficacy and safety.
    Ferdinand KC
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):993-1001. PubMed ID: 16292990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. F.D.A. approves a heart drug for African-Americans.
    Saul S
    N Y Times Web; 2005 Jun; ():C2. PubMed ID: 15981400
    [No Abstract]   [Full Text] [Related]  

  • 20. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
    Taylor AL; Ziesche S; Yancy C; Carson P; D'Agostino R; Ferdinand K; Taylor M; Adams K; Sabolinski M; Worcel M; Cohn JN;
    N Engl J Med; 2004 Nov; 351(20):2049-57. PubMed ID: 15533851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.